{
  "input": {
    "mode": "build_counterchain",
    "query": {
      "entity": "Familial tumour syndromes of the central and peripheral nervous system",
      "relation": "contraindication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_vemurafenib",
          "name": "Vemurafenib"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_dabrafenib",
          "name": "Dabrafenib"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_trametinib",
          "name": "Trametinib"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_sunitinib",
          "name": "Sunitinib"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_sorafenib",
          "name": "Sorafenib"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_everolimus",
          "name": "Everolimus"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_cyclophosphamide",
          "name": "Cyclophosphamide"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_irinotecan",
          "name": "Irinotecan"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_etoposide",
          "name": "Etoposide"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_carboplatin",
          "name": "Carboplatin"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_temozolomide",
          "name": "Temozolomide"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_bevacizumab",
          "name": "Bevacizumab"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "n_ot_vemurafenib",
          "type": "Target",
          "label": "OffTarget_Vemurafenib",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_vemurafenib",
          "type": "Pathway",
          "label": "RiskPathway_Vemurafenib",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_vemurafenib",
          "type": "Phenotype",
          "label": "AdversePhenotype_Vemurafenib",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_dabrafenib",
          "type": "Target",
          "label": "OffTarget_Dabrafenib",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_dabrafenib",
          "type": "Pathway",
          "label": "RiskPathway_Dabrafenib",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_dabrafenib",
          "type": "Phenotype",
          "label": "AdversePhenotype_Dabrafenib",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_trametinib",
          "type": "Target",
          "label": "OffTarget_Trametinib",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_trametinib",
          "type": "Pathway",
          "label": "RiskPathway_Trametinib",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_trametinib",
          "type": "Phenotype",
          "label": "AdversePhenotype_Trametinib",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_sunitinib",
          "type": "Target",
          "label": "OffTarget_Sunitinib",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_sunitinib",
          "type": "Pathway",
          "label": "RiskPathway_Sunitinib",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_sunitinib",
          "type": "Phenotype",
          "label": "AdversePhenotype_Sunitinib",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_sorafenib",
          "type": "Target",
          "label": "OffTarget_Sorafenib",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_sorafenib",
          "type": "Pathway",
          "label": "RiskPathway_Sorafenib",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_sorafenib",
          "type": "Phenotype",
          "label": "AdversePhenotype_Sorafenib",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_everolimus",
          "type": "Target",
          "label": "OffTarget_Everolimus",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_everolimus",
          "type": "Pathway",
          "label": "RiskPathway_Everolimus",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_everolimus",
          "type": "Phenotype",
          "label": "AdversePhenotype_Everolimus",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_cyclophosphamide",
          "type": "Target",
          "label": "OffTarget_Cyclophosphamide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_cyclophosphamide",
          "type": "Pathway",
          "label": "RiskPathway_Cyclophosphamide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_cyclophosphamide",
          "type": "Phenotype",
          "label": "AdversePhenotype_Cyclophosphamide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_irinotecan",
          "type": "Target",
          "label": "OffTarget_Irinotecan",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_irinotecan",
          "type": "Pathway",
          "label": "RiskPathway_Irinotecan",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_irinotecan",
          "type": "Phenotype",
          "label": "AdversePhenotype_Irinotecan",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_etoposide",
          "type": "Target",
          "label": "OffTarget_Etoposide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_etoposide",
          "type": "Pathway",
          "label": "RiskPathway_Etoposide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_etoposide",
          "type": "Phenotype",
          "label": "AdversePhenotype_Etoposide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_carboplatin",
          "type": "Target",
          "label": "OffTarget_Carboplatin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_carboplatin",
          "type": "Pathway",
          "label": "RiskPathway_Carboplatin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_carboplatin",
          "type": "Phenotype",
          "label": "AdversePhenotype_Carboplatin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_temozolomide",
          "type": "Target",
          "label": "OffTarget_Temozolomide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_temozolomide",
          "type": "Pathway",
          "label": "RiskPathway_Temozolomide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_temozolomide",
          "type": "Phenotype",
          "label": "AdversePhenotype_Temozolomide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_bevacizumab",
          "type": "Target",
          "label": "OffTarget_Bevacizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_bevacizumab",
          "type": "Pathway",
          "label": "RiskPathway_Bevacizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_bevacizumab",
          "type": "Phenotype",
          "label": "AdversePhenotype_Bevacizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_vemurafenib",
          "target": "n_ot_vemurafenib",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能靶点作用导致不良反应"
        },
        {
          "source": "n_ot_vemurafenib",
          "target": "n_rp_vemurafenib",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_rp_vemurafenib",
          "target": "n_adv_vemurafenib",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能引发肿瘤等不良表型"
        },
        {
          "source": "n_adv_vemurafenib",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若存在风险，可能抵消疗效"
        },
        {
          "source": "drug_dabrafenib",
          "target": "n_ot_dabrafenib",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能靶点作用导致不良反应"
        },
        {
          "source": "n_ot_dabrafenib",
          "target": "n_rp_dabrafenib",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_rp_dabrafenib",
          "target": "n_adv_dabrafenib",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能引发肿瘤等不良表型"
        },
        {
          "source": "n_adv_dabrafenib",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若存在风险，可能抵消疗效"
        },
        {
          "source": "drug_trametinib",
          "target": "n_ot_trametinib",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能靶点作用导致不良反应"
        },
        {
          "source": "n_ot_trametinib",
          "target": "n_rp_trametinib",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_rp_trametinib",
          "target": "n_adv_trametinib",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能引发肿瘤等不良表型"
        },
        {
          "source": "n_adv_trametinib",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若存在风险，可能抵消疗效"
        },
        {
          "source": "drug_sunitinib",
          "target": "n_ot_sunitinib",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能靶点作用导致不良反应"
        },
        {
          "source": "n_ot_sunitinib",
          "target": "n_rp_sunitinib",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_rp_sunitinib",
          "target": "n_adv_sunitinib",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能引发肿瘤等不良表型"
        },
        {
          "source": "n_adv_sunitinib",
          "target": "H4",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若存在风险，可能抵消疗效"
        },
        {
          "source": "drug_sorafenib",
          "target": "n_ot_sorafenib",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能靶点作用导致不良反应"
        },
        {
          "source": "n_ot_sorafenib",
          "target": "n_rp_sorafenib",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_rp_sorafenib",
          "target": "n_adv_sorafenib",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能引发肿瘤等不良表型"
        },
        {
          "source": "n_adv_sorafenib",
          "target": "H5",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若存在风险，可能抵消疗效"
        },
        {
          "source": "drug_everolimus",
          "target": "n_ot_everolimus",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能靶点作用导致不良反应"
        },
        {
          "source": "n_ot_everolimus",
          "target": "n_rp_everolimus",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_rp_everolimus",
          "target": "n_adv_everolimus",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能引发肿瘤等不良表型"
        },
        {
          "source": "n_adv_everolimus",
          "target": "H6",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若存在风险，可能抵消疗效"
        },
        {
          "source": "drug_cyclophosphamide",
          "target": "n_ot_cyclophosphamide",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能靶点作用导致不良反应"
        },
        {
          "source": "n_ot_cyclophosphamide",
          "target": "n_rp_cyclophosphamide",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_rp_cyclophosphamide",
          "target": "n_adv_cyclophosphamide",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能引发肿瘤等不良表型"
        },
        {
          "source": "n_adv_cyclophosphamide",
          "target": "H7",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若存在风险，可能抵消疗效"
        },
        {
          "source": "drug_irinotecan",
          "target": "n_ot_irinotecan",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能靶点作用导致不良反应"
        },
        {
          "source": "n_ot_irinotecan",
          "target": "n_rp_irinotecan",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_rp_irinotecan",
          "target": "n_adv_irinotecan",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能引发肿瘤等不良表型"
        },
        {
          "source": "n_adv_irinotecan",
          "target": "H8",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若存在风险，可能抵消疗效"
        },
        {
          "source": "drug_etoposide",
          "target": "n_ot_etoposide",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能靶点作用导致不良反应"
        },
        {
          "source": "n_ot_etoposide",
          "target": "n_rp_etoposide",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_rp_etoposide",
          "target": "n_adv_etoposide",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能引发肿瘤等不良表型"
        },
        {
          "source": "n_adv_etoposide",
          "target": "H9",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若存在风险，可能抵消疗效"
        },
        {
          "source": "drug_carboplatin",
          "target": "n_ot_carboplatin",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能靶点作用导致不良反应"
        },
        {
          "source": "n_ot_carboplatin",
          "target": "n_rp_carboplatin",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_rp_carboplatin",
          "target": "n_adv_carboplatin",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能引发肿瘤等不良表型"
        },
        {
          "source": "n_adv_carboplatin",
          "target": "H10",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若存在风险，可能抵消疗效"
        },
        {
          "source": "drug_temozolomide",
          "target": "n_ot_temozolomide",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能靶点作用导致不良反应"
        },
        {
          "source": "n_ot_temozolomide",
          "target": "n_rp_temozolomide",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_rp_temozolomide",
          "target": "n_adv_temozolomide",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能引发肿瘤等不良表型"
        },
        {
          "source": "n_adv_temozolomide",
          "target": "H11",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若存在风险，可能抵消疗效"
        },
        {
          "source": "drug_bevacizumab",
          "target": "n_ot_bevacizumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能靶点作用导致不良反应"
        },
        {
          "source": "n_ot_bevacizumab",
          "target": "n_rp_bevacizumab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_rp_bevacizumab",
          "target": "n_adv_bevacizumab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能引发肿瘤等不良表型"
        },
        {
          "source": "n_adv_bevacizumab",
          "target": "H12",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若存在风险，可能抵消疗效"
        }
      ],
      "merge": [],
      "set_weights": [],
      "conflict_hotspots": []
    },
    "counterclaims": [],
    "assumptions_challenged": [],
    "falsification_tests": [],
    "next_focus_for_pi": []
  }
}